Direct MYD88L265P gene detection for diffuse large B-cell lymphoma (DLBCL) via a miniaturised CRISPR/dCas9-based sensing chip

Lab on a Chip ◽  
2022 ◽  
Author(s):  
Chongyang Liang ◽  
weihan sun ◽  
wei guo ◽  
zhiyi liu ◽  
Sennan Qiao ◽  
...  

Traditional methods for single-nucleotide variants based on the amplification and the fluorescent signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised...

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2478-2478
Author(s):  
Miguel Ángel Gutiérrez-Monreal ◽  
Luis Villela ◽  
Yocanxochitl Perfecto ◽  
Samuel Kettenhofen ◽  
Guy Cardineau ◽  
...  

Abstract Abstract 2478 In Mexico, diffuse large B-cell lymphoma (DLBCL) is the most common histological non-Hodgkin's lymphoma (NHL) subtype and is observed in up to 48% of all diagnoses of lymphoma. It has recently been hypothesized that circadian disruption may have a connection with lymphomagenesis. The circadian clock maintains biological rhythms over a cycle of approximately 24 hours, and many physiological functions in the human body are regulated by this system. The disruption of the circadian cycle may negatively affect cellular function, potentially leading to increased susceptibility to certain malignancies. Evidence in support of this association has been provided by epidemiological studies that demonstrate that night-time work significantly increased the risk of NHL in men, the overall relative risk being 1.10 (95%CI = 1.03–1.19, p = 0.010)(Lahti et al., Int J Cancer 2008). The study was performed to determinate if functional single nucleotide polymorphisms (SNP) in circadian rhythm genes are associated with the presence of DLBCL in Mexican patients. A molecular mechanism to regulate the circadian rhythm has been identified, where nine genes have been involved: clock, npas2, bmal1, per1-3, cry1-2, and csnk1e. Recent studies have shown that approximately 10% of genes exhibit circadian patterns of expression in a given tissue, and 10% of these clock-controlled genes identified regulate either cell proliferation or apoptosis. For this current study, SNPs were evaluated in DNA samples isolated from histopathologically-confirmed DLBCL patients (N=30) and healthy volunteers (N=50) as a control population. Samples were provided by Hospital Regional de Especialidades IMSS No. 25 and Hospital Metropolitano, in Monterrey, Nuevo Leon, Mexico. The selection of functional SNPs was made using a bioinformatic tool called Function Analysis and Selection Tool for Single Nucleotide Polymorphisms (FASTSNP)(Yuan et al., Nucl. Acids Res 2006). Six genes that regulate the circadian rhythm were submitted to FASTSNP, and 13 high-risk SNPs were used for this study. The results provided were npas2 rs11541353, per1 rs3027189, rs3027180, and rs3027177; per2 rs2340885, and rs3739068; per3 rs228697, rs2640905, rs12078704, and rs57875989; tim rs2291739, and rs2638290; and cry2 rs2863712. Primers were designed for the 13 high-risk SNPs. The SNPs were amplified by PCR in a 96-well plate. Alleles were determined by presence of the resultant bands in an agarose gel electrophoresis. SNPs analysis showed that DLBCL patients were mutated in 93.3% (28/30), while the population of controls were only in 74.0% (37/50) who presented with mutations (p = 0.023). The rs2291739 variant of the tim gene was the most frequent homozygous mutant found in at least 50% of both controls and patients. Two SNPs were found to be statistically significant associated with DLBCL, these were per1 rs3027189 (p = 0.006) and cry2 rs2863712 (p = 0.002). The per1 gene plays an important role in regulating growth and DNA damage control and also interacts with proteins in the cell-cycle pathway. CRY2 has been shown to alter genes associated with immune response and hematological system development. These results suggest that these two genes might play an important role in influencing biological pathways relevant for lymphomagenesis. These findings contribute in part to the recent research that links the disruption of circadian rhythm with the processes of lymphomagenesis. Further studies are warranted. This study was supported by Catedra de Hematologia y Cancer from Tecnologico de Monterrey. Disclosures: No relevant conflicts of interest to declare.


Author(s):  
Berezina O.V. ◽  
Pospelova T.I.

The results of original studies often show the different effects of single nucleotide polymorphisms (SNPs) in folate pathway genes on the risk of diffuse large B-cell lymphoma (DLBCL). Meta-analysis allows integrating the accumulated data. To assess the impact MTHFR C677T and A1298C, MTR A2756G, SHMT1 C1420T, CBS 844ins68 on the risk of DLBCL, we performed a meta-analysis of the case-control studies among the Caucasian population. The 12 publications were selected for the study according to the selection criteria. Taking into account the heterogeneity of the data, the calculation was performed using a random effects model. There was no association of MTHFR A1298C, MTR A2756G, SHMT1 C1420T, CBS 844ins68 with the risk of DLBCL. The meta-analysis revealed an association of the rare genotype MTHFR 677T/T with an increased risk of DLBCL (OR 1.2 CI [1.008-1.572], p = 0.041).


2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Amanda Vansan Marangon ◽  
Cristiane Maria Colli ◽  
Daniela Maira Cardozo ◽  
Jeane Eliete Laguila Visentainer ◽  
Ana Maria Sell ◽  
...  

The purpose of this study was to assess the influence of single-nucleotide polymorphisms (SNPs) on cytokine genes in the development of diffuse large B-cell lymphoma (DLBCL). One hundred and twelve patients and 221 controls were investigated. Among them, 97 patients treated with R-CHOP were subdivided into two groups: (i) complete remission of the disease and (ii) patients who progressed to death, relapsed, or had disease progression. The SNPs investigated by PCR-SSP were TNF -308G>A (rs1800629), IFNG +874A>T (rs2430561), IL6 -174G>C (rs1800795), IL10 -1082A>G (rs1800896), IL10 -819C>T (rs1800871), IL10 -592C>A (rs1800872), and TGFB1 codon10T>C (rs1982073) and codon25G>C (rs1800471). In general, the genotypes that have been associated in the literature with lower production or intermediate production of IL-10 and higher production of IFN-γ were associated with the protection of the development of the disease, possibly favoring the Th1 immune response and diminishing the capacity of cell proliferation. However, patients receiving R-CHOP treatment presented unfavorable prognoses in the presence of genotypes related to the intermediate production of IL-10 and high production of TGF-β1, indicating that cytokines may be related to the response to treatment and action mechanisms of Rituximab.


2017 ◽  
Vol 4 (1) ◽  
pp. e000187 ◽  
Author(s):  
Sasha Bernatsky ◽  
Héctor A Velásquez García ◽  
John J Spinelli ◽  
Patrick Gaffney ◽  
Karin E Smedby ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document